Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

Related Issuers

PX TALK: Boots $2bn equiv (EUR/GBP) 7NC3 sr sec notes 2-part, EUR 5.50-5.75%, GBP 7.50-7.75%

HYC US Market: Deal Flow - GeneralHYC European Market: Deal Flow - General

Boots Group Finco LP/The Boots Group Luxco Sarl (BOOTSFN) US$2bn equivalent 144A/Reg S sr sec notes 2-part. B1/B+/BB (stable/stable/stable). Via GS (B&D EUR & GBP)/UBS (B&D US$) jt physical books/JPM/Citi/DB/WFS/Mizuho/PNC/RBC/CIBC/Citizens/Scotia/TD/BNP/FITB/TSI/USB jt books. No reg rights. List ISE. NY law.

- Minimum US$750m (from US$750m) equivalent in EUR due 2032 (7y). NC3 (MWC B+50bp). Equity claw:3y 40%. Special call: 10% per year the first 3 years at 103. CoC at 101. Denoms: 100x1. IPT: 6.00% area. Revised IPT: 5.75%-6.00%. Price talk: 5.50%-5.75%.

- Minimum US$500m (from US$750m) equivalent in GBP due 2032 (7y). NC3 (MWC G+50bp). Equity claw:3y 40%. Special call: 10% per year the first 3 years at 103. CoC at 101. Denoms: 100x1. IPT: 8.00% area. Revised IPT: 7.75%-8.00%. Price talk: 7.50%-7.75%.

Dropped: US$500m due 2032 (7y). NC3 (MWC T+50bp). Equity claw:3y 40%. Special call: 10% per year the first 3 years at 103. CoC at 101. Denoms: 200x1. IPT: Mid-high 7s.

Did investor call at 2pm UKT/9am NYT 07/15. Books close at 5pm UKT/12pm NYT 07/17. Pricing on 07/18, concurrently with the term loan, originally pricing 07/22. UOP: along with US$2.25bn equivalent (US$750m, US$1bn equivalent in EUR, and US$500m equivalent in GBP) sr sec term loans, and US$1.2bn pfd equity via Goldentree, to fund the LBO of Boots, which will be spun off from Walgreens Boots Alliance (WBA) by Sycamore Partners for US$11.45 per share and one divested asset proceeds right (up to $3 per DAP right (or approx $2.7bn total) from the future monetization of VillageMD Business) for $10bn equity value or a potential total value of up to $23.7bn, including net debt and opioid settlements. Sycamore will contribute US$2.5bn in equity. Biz: UK based pharmacy chain. (Acquisition announced 03/06/25).

Netroadshow direct link: https://urldefense.com/v3/__https:/www.netroadshow.com/nrs/home/*!/?show=4bad713c__;Iw!!O2kDR7mm-zSJ!p15OEkS-zfiqY6i4rcDyYdWZJg-8-EBKHRzujEPaZtlJQx-GRFJAbMJv4a0TOd2AHVJBQ3bQEbwCzx8$. Access code: 2025-Boots.

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.